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1. Introduction 
Molecular recognition relies on the ability to design and 
synthesize appropriate substrates with predictable geometries and 
binding sites.
1
 Towards this end Tröger’s base
2
 1 has been used 
to great effect by a number groups within the context of 
molecular recognition because it contains a rigid predictable 
structure, heteroatoms capable of binding events and importantly 
a chiral cavity.
3,4
 While Tröger’s base has proved effective as a 
chiral cleft molecule, a number of carbocyclic and heterocyclic 
analogues have also been also investigated as possible 
surrogates.
5
 The carbocyclic cleft molecule 2 was initially 
reported in 1960 by Stetter
6
 but was fully characterized and 
resolved in 1975 by Tatemitsu et al.
7
 Significant advances in the 
functionalization of 2 have been developed by the Harding 
group
8
 and an excellent review on its development/ uses has been 
published (Figure 1).
9 
 
Figure 1. Racemic Tröger,s Base (±)-1, and (+)-2 and (-)-2 
Of particular interest to our group is the reduced version of 2.  
Treatment of 2 with excess reducing agent results in the 
formation of the bis-hydroxyl carbocycle 3, where both hydroxyl 
groups are directed into the chiral cavity. This potentially gives a 
ligand which can bind substrates via metal or Brønsted base / 
acid binding interactions within a chiral cavity (Scheme 1). 
 
 
 
Scheme 1.  Reduction of 2 to give diol 3. 
 
To date the only reported functionalization of these hydroxyl 
groups has been the attachment of simple esters (bromobenzoate, 
acetate and menthoxy acetyl) and the synthesis of cyclic 
ethers.
7,10
 The dibromobenzoate and diacetate derivatives were 
synthesized for characterization reasons, the dimenthoxy acetate 
was synthesized for separation purposes and the cyclic ethers 
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were synthesized for a study on the use of 3 as a resolution agent 
in chiral-hplc. However, the synthesis of 3 containing tethered 
heterocyclic groups capable of metal binding or containing 
Brønsted base / acid binding sites has yet to be reported. Indeed, 
the incorporation of tethered heterocycles on to 3 could allow for 
molecular recognition processes. An ideal heterocycle to be 
attached to these hydroxyl groups contained in 3 would be the 
pyridyl motif.  During a research programme aimed at utilizing 3 
in catalysis and molecular recognition events we required 
methods for simple diesterification and mono/dialkyation of 3 
with 2-, 3-, and 4-pyridyl subunits (Figure 2).  Diesterification 
and dietherification would give the diesters 4a-c, and diethers 6a-
c, both of which would contain pyridyl units capable of metal and 
Brønsted base interactions.  Alternatively, synthesis of 5a-c 
would potentially give ligands containing both a Brønsted base 
(the pyridyl unit) and the Brønsted acid site within the same 
framework.  We would now like to report our efforts in 
developing methods for the synthesis of carbocyclic cleft 
molecules containing metal binding and Brønsted base/acid sites 
related to carbocycle 3 and the solid state X-ray analysis of the 
synthesized ligands. 
 
 
 
Figure 2.  Ligands containing pyridyl units 
2. Results and Discussion 
2.1 Synthesis 
Our synthesis began with racemic carbocycle (±)-2 which could 
be obtained in multigram amounts using an adapted literature 
method (Scheme 2).
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Scheme 2. Diesterification of (±)-3. 
Reduction of the dione (±)-2 with an excess of NaBH4 occurs 
stereo-specifically to give the diol (±)-3, where the hydroxyl 
groups are orientated into the cavity of the bicycle.  Initial 
attempts at formation of the diester using only 2.0 equivalents of 
4-pyridyl acid chloride hydrochloride salt relative to the (±)-3 in 
CH2Cl2 with excess NEt3 at room temperature for 24 h resulted in 
a mixture of the mono and diesters. Moreover, heating of this 
mixture proved ineffective as did the addition of DMAP.  
However, treatment of the diol with 3.0 equivalents of the 4-
pyridyl acid chloride hydrochloride salt and exchanging the 
solvent for pyridine with catalytic DMAP at 50ºC for 16 h did 
yield the desired dipyridyl ester (±)-4c in moderate to good 
yields.  Repeating this procedure with the 2- and 3-pyridyl acid 
chloride hydrochlorides gave their respective dipyridyl esters, 
(±)-4a and (±)-4b in good yield. However, the yield of the (±)-4a 
remained a disappointing 62 % with the remaining mass balance 
being accounted for by the isolation of the mono 2-pyridyl ester 
(±)-4d in 22% yield. 
Initial attempts at dietherification of (±)-3, using 2-, 3-, and 4-
bromomethylpyridyl hydrobromide salt as the alkylating agent 
and using NaH as the base, gave unexpectedly the monoalkylated 
product (±)-5a in 87% yield (Scheme 3). Even when the reaction 
was undertaken with excess base and excess alkylating agent the 
monoalkyated product predominated. While this result was 
initially disappointing it did give us a facile entry into the 
monoalkylated ligands.  Accordingly, (±)-3 was treated with 3- 
and 4-bromomethylpyridyl hydrobromide salt under these 
conditions giving the monoalkylated products (±)-5b and (±)-5c 
in 88% and 92% yield, respectively. In an attempt to access the 
dialkylated substrates the solvent was switched from THF to 
DMF with a concomitant increase in reaction temperature, but 
this led to an unsatisfactory mixture of the mono and diethers 
whose separation proved problematic. However, dialkylation of 
(±)-3 was achieved using an adapted method of Ley and 
Heaney.
11
 Hence, treatment of (±)-3 with the desired 2-
bromomethylpyridyl hydrobromide salt (2.2 eq.) in DMSO and 
excess KO
t
Bu (4.4 eq.) gave the dialkyated carbocycles (±)-6a in 
excellent yield of 87% (Scheme 3). This procedure was then 
repeated for the 3- and 4-bromomethylpyridyl hydrobromide 
salts giving excellent yields of the dialkylated products (±)-6b 
and (±)-6c in 79% and 94% yield, respectively. 
 
Scheme 3. Selective mono and dietherification of (±)-3. 
 
2.2 X-ray crystallographic analysis 
 
Crystals suitable for X-ray analysis were obtained for compounds 
(±)-4b, (±)-4c, (±)-4d, and (±)-5c.
12
  While (±)-4c, (±)-4d, and 
(±)-5c crystallized as racemates, (±)-4b resolved on 
crystallization and the (+)-4b was studied crystallographically as 
the mono-dichloromethane solvate for which the absolute 
structure was reliably determined (see Table 1, supplementary 
information). Due to small crystal dimensions two data sets, (±)-
4c and (±)-5c, were collected using synchrotron radiation at the 
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ALS. Figure 3 shows the molecular structure of (+)-4b and 
clearly indicates that the orientation of the complexing pyridyl 
units is directed into the cavity of the cleft bicycle as expected. 
The molecule lies on a crystallographic two-fold axis. The 
dichloromethane solvate molecule resides in the cleft and is 
bound via a pair of C–H···π interactions; H···ring – centroid = 
2.58 Å.  
 
Figure 3. Molecular structure of (+)-4b·CH2Cl2 showing pyridyl 
groups pointing ‘downwards’ into the cleft and the C–H···π binding 
of the dichloromethane solvate. 
 
Packing plots shown in Figure 4a and b show the way in which 
the pyridyl groups hydrogen bond to neighboring molecules via 
relatively weak C–H···N and C–H···O interactions (H···N/O = 
2.50/2.60 Å respectively) forming a micro-porous 3D structure. 
 
 
 
Figure 4 (a) Detail of hydrogen bonding between molecules in (+)-
4b, (b) 3D micro-porous packing with dichloromethane encapsulated 
within clefts. 
 
In (±)-4c the pyridyl groups also point towards the cleft. 
Molecules stack on top of each other, each twisted 90° relative to 
its neighbours ‘above/below’ (Figure 5). The C–H···π 
interactions are ca. 3.14 Å. Pairs of pyridyl rings π···π stack with 
a closest C···C separation of ca. 3.36 Å, and there are further 
weak H-bonds of the C–H···N and C–H···O types in the range 
2.54 – 2.74 Å linking molecules into a weakly-bound 3D network 
(Figure 6). 
 
 
Figure 5 (a) A pair of stacked molecules of (±)-4c, (b) packing in 
(±)-4c showing weak H-bond contacts and overall 3D network. 
Viewed parallel to the stacking direction. 
 
In (±)-4d groups of six molecules form into finite rings, rather 
than infinite stacks as in (±)-4c, yet still have the internal clefts 
filled by the external surface of the neighbouring molecule. The 
hydroxyl groups form a chair shaped H-bonded 12-membered 
ring about the crystallographic 3 axis (Figure 6(a)). Neighbouring 
six-membered rings overlap pyridyl groups resulting in π···π 
stacking parallel to the crystallographic c axis with C···C and 
C···N separations in the range 3.26 – 3.53 Å (Figure 6(b)). 
 
 
Figure 6 (a) Groups of six molecules of (±)-4d stacked into a ring 
and H-bonded, (b) π···π Stacking of pyridyl groups of neighbouring 
rings of (±)-4d molecules. 
 
In (±)-5a the packing is rather simpler, with 1D chains formed 
parallel to the crystallographic b axis via strong O–H···N H-bond 
interactions with H···N = 1.95 Å (Figure 7(a)). As in the above 
examples the cleft is again filled, this time with a molecule from 
the chain ‘above/below’ via C–H···π interactions of 2.82 and 
3.15 Å (Figure 7(b)). Compared with (±)-4c one interaction is 
similar in length and one is significantly shorter. 
 
Figure 7 (a) Packing in (±)-5a showing 1D H-bonded chains parallel 
to b, (b) C–H···π interactions between H-bonded chains in (±)-5a. 
3. Conclusions 
In conclusion, we have disclosed a convenient method for the 
selective functionalization of the carbocyclic cleft molecule (±)-3 
and, for the first time, with heterocyclic groups capable of metal 
binding and containing both Brønsted base / acid sites.  Single 
crystal X-ray analysis of (+)-4b·CH2Cl2, (±)-4c, (±)-4d, and (±)-
5c all indicate the orientation of the complexing pyridyl groups 
are directed into the cavity. The clefts are filled with either 
solvent molecules or external surfaces of other cleft molecules 
via C–H···π interactions, demonstrating their ability to take up 
molecules with the appropriate shape and, potentially, chirality. 
With the ability to access optically pure 3 these new heterocyclic 
cleft molecules provide us with a new family of chiral ligands 
capable of molecular recognition and catalysis processes as well 
as in the development of novel chiral scaffolds.  The use of these 
ligands in these areas is currently under investigation within our 
group and will be reported on in due course. 
a) b) 
a) b) 
a) b) 
a) 
b) 
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4. Experimental procedures 
4.1 General 
Commercially available reagents and solvents were used 
throughout without further purification, except tetrahydrofuran 
(benzophenone/Na) and dichloromethane (CaH) which were 
freshly distilled.  Light petroleum refers to the fraction with bp 
40-60 ºC. Thin layer chromatography was carried out on GF254 
aluminium foil backed plates. The plates were visualized under 
UV light and/or anisaldehyde stain. Flash chromatography was 
carried out using 60 H silica or Matrix silica 60, with the eluent 
specified. IR spectra were recorded using FTIR Spectrometer as 
solutions using chloroform as solvent. 
1
H and 
13
C NMR spectra 
were recorded using 400 MHz NMR machine (
1
H 400 MHz and 
13
C 100 MHz respectively); chemical shifts are quoted in ppm 
and coupling constants, J, are quoted in Hz; d-Chloroform was 
used throughout unless otherwise stated. In the 
13
C spectra, 
signals corresponding to C, CH, CH2 or CH3 groups, as assigned 
from DEPT, are noted. Spectra were calibrated to residual solvent 
peaks.  High and low resolution mass spectra were carried out on 
an orbi-trap high resolution mass spectrometer. Optical rotation 
measurements were recorded using chloroform as solvent.  
Melting points are uncorrected. Compounds 2 was synthesized 
using known literature procedures.
7,8b
 
4.2 General diesterification method.  
To a solution of the diol (±)-3 (0.100 g, 0.397 mmol) in pyridine 
(1.00 mL) was added the pyridyl acidchloride HCl salt (0.211 g, 
1.190 mmol) followed by DMAP (catalytic, 0.01 g) and the 
resultant reaction mixture heated at 50ºC overnight under an N2 
atmosphere.  The reaction mixture was then cooled, diluted with 
CH2Cl2 and washed sequentially with sat. NaHCO3 and brine.  
The organic layers were then dried (Na2SO4), filtered and the 
solvent removed in vacuo.  The crude solid was then either 
recrystallized or purified by column chromatography.  This gave 
the following compounds; 
(±)-4,8-Di(2,3:6,7-dibenzobicyclo[3.3.1]nona-2,6-
diene)picolinate, (±)-4a. Colourless crystals (0.90 g, 62%) m.p. 
283-285.5ºC decomp.; Rf (3:1, ethyl acetate:petroleum ether) 0.4; 
νmax (solution, CHCl3) 3013, 1733, 1304, 1382, 1242, 1139 cm
-1
; 
δH (400 MHz; CDCl3) 9.18 (m, 2H), 8.77 (dd, J = 1.7, 4.8 Hz, 
2H), 8.26 – 8.24 (m, 2H), 7.37 – 7.34 (m, 2H), 7.14 – 7.13 (m, 
4H), 7.04 – 7.02 (m, 2H), 6.92 (d, J = 7.6 Hz, 2H), 6.55 (d, J = 
5.7 Hz, 2H), 3.67 – 3.65 (m, 2H), 2.56 – 2.55 (m, 2H);  δC (100 
MHz; CDCl3) 165.43 (C), 153.88 (CH), 151.33 (CH), 137.42 
(CH), 134.78 (C), 134.16 (C), 131.10 (CH), 127.80 (CH), 127.12 
(CH), 126.87 (CH), 125.88 (C), 123.47 (CH), 75.27 (CH), 35.96 
(CH), 29.00 (CH2); HRMS MH
+
, C29H23N2O4, found 463.1636, 
requires MH
+
 463.1658. 
(±)-4,8-Di(2,3:6,7-Dibenzobicyclo[3.3.1]nona-2,6-
diene)nicotinate, (±)-4b. Colourless crystals (0.145  g, 79%) m.p. 
227-228.5ºC decomp.; Rf (3:1, ethyl acetate: petroleum ether) 
0.6; νmax (solution, CHCl3) 3014, 1733, 1304, 1243, 1139 cm
-1
; δH 
(400 MHz; CDCl3) 8.80 (d, J = 0.8 Hz, 2H), 7.92 (d, J = 7.6 Hz, 
2H), 7.75 – 7.74 (m, 2H), 7.46 (dd, J = 4.8, 5.6 Hz, 2H), 7.20 – 
7.12 (m, 4H), 7.00 – 6.98 (m, 2H), 6.95 (d, J = 7.6 Hz, 2H), 6.60 
(d, J = 5.6 Hz, 2H), 3.72 – 3.71 (m, 2H), 2.56 – 2.55 (m, 2H); δC 
(100 MHz; CDCl3) 164.85 (C), 150.43 (CH), 147.83 (C), 137.10 
(CH), 134.89 (C), 134.32 (CH), 131.21 (CH), 127.14 (CH), 
127.13 (CH), 127.00 (CH), 126.96 (CH), 125.35 (CH), 75.70 
(CH), 35.74 (CH), 28.97 (CH2); HRMS MNa
+
, C29H22N2O4Na, 
found 485.1455, requires MNa
+
 485.1477. 
(±)-4,8-Di(2,3:6,7-dibenzobicyclo[3.3.1]nona-2,6-
diene)isonicotinate, (±)-4c. Colourless crystals (0.142 g, 77%) 
m.p. 281-285ºC decomp.; Rf (3:1, ethyl acetate:petroleum ether) 
0.68; νmax (solution, CHCl3) 3011, 1738, 1304, 1282, 1242, 1139 
cm
-1
; δH (400 MHz; CDCl3) 8.83 – 8.81 (m, 4H), 7.89 – 7.85 (m, 
4H), 7.18 – 7.11 (m, 4H), 7.10 – 7.06 (m, 2H), 6.97 (d, J = 7.6 
Hz, 2H), 6.62 (d, J = 5.6 Hz, 2H), 3.76 – 3.74 (m, 2H), 2.66 – 
2.64 (m, 2H); δC (100 MHz; CDCl3) 165.26 (C), 150.84 (CH), 
137.11 (C), 134.71 (C), 133.98 (C), 131.13 (CH), 127.86 (CH), 
127.16 (CH), 129.88 (CH), 123.09 (CH), 75.60 (CH), 35.80 
(CH), 28.93 (CH2); HRMS MH
+
, C29H23N2O4, found 463.1638, 
requires MH
+
 463.1658. 
(±)-{(4-Hydroxy)-8-picolinate}-2,3:6,7 
dibenzobicyclo[3.3.1]nona-2,6-diene, (±)-4d. Colourless crystals 
(0.032 g, 22%) m.p. 157 - 159ºC; Rf (3:1, ethyl acetate:petroleum 
ether) 0.4; νmax (solution, CHCl3) 3566, 2936, 1736, 1584, 1489, 
1243 cm
-1
; δH (400 MHz; CDCl3) 8.83 – 8.82 (m, 1H), 7.96 (d, J 
= 7.6 Hz, 1H), 7.82 – 7.80 (m, 1H), 7.53 – 7.49 (m, 2H), 7.36 – 
7.35 (m, 1H), 7.36 – 7.33 (m, 4H), 7.09 – 7.06 (m, 1H), 7.05 – 
7.04 (m, 1H), 6.60 (d, J = 5.2 Hz, 1H), 5.11 – 5.08 (m, 1H), 3.65 
(s, 1H), 3.37 (s, 1H), 2.61 – 2.56 (m, 1H), 2.47 – 2.43 (m, 1H), 
1.59 (d, J = 11.6 Hz, 1H); δH (100 MHz; CDCl3) 164.85 (C), 
150.41 (CH), 147.86 (C), 139.16 (C), 137.04 (CH), 134.79 (C), 
134.63 (C), 134.16 (C), 130.79 (CH), 130.58 (CH), 127.81 (CH), 
127.76 (CH), 127.42 (CH), 127.27 (CH), 127.16 (CH), 127.08 
(CH), 126.66 (CH), 125.32 (CH), 75.91 (CH), 72.51 (CH), 39.08 
(CH), 36.11 (CH), 29.16 (CH2); HRMS MH
-
, C23H19NO3, found 
356.1296, requires MH
-
 356.1287. 
4.3 General method for monoalkylation.  
To a solution of the diol (±)-3 (0.100 g, 0.397 mmol) in dry THF 
(5.00 mL) was added the pyridylmethyl bromide (0.221 g, 0.872 
mmol, (note that the HBr salt was neutralized with NEt3 (0.121 
mL, 0.872 mmol) in THF (1.00 mL) prior to addition and 
therefore added as a solution) and the reaction mixture stirred at 
0ºC under N2. To this mixture was added NaH (3.0 equiv.) and 
the subsequent reaction mixture was then allowed to warm to 
room temperature and stirred over night.  After this period the 
reaction mixture was cooled to 0ºC, sat. NH4Cl added and the 
mixture warmed to room temperature.  The reaction mixture then 
diluted with CH2Cl2 and the combined organic layers were then 
washed with brine, dried (Na2SO4), filtered and the solvent 
removed in vacuo.  The crude solid was then purified by column 
chromatography.  This gave the following compounds; 
(±)-{(4-Hydroxy)-8-(pyridin-2-yl)methoxy}-2,3:6,7-
dibenzobicyclo[3.3.1]nona-2,6-diene, (±)-5a. Oil (0.119 g, 87%) 
Rf 3:1 ethyl acetate:petroleum ether) 0.35; νmax (solution, CHCl3) 
3567, 3015, 2925, 1604, 1102, 1037 cm
-1
; δH (400 MHz; CDCl3) 
8.59 (d, J = 4.4 Hz, 1H), 7.72 (dt, J = 2.0, 8.0 Hz, 1H), 7.60 (d, J 
= 10.0 Hz, 1H), 7.52 – 7.49 (m, 2H), 7.29 – 7.27 (m, 3H), 7.23 – 
7.08 (m, 4H), 5.27 (d, J = 13.2 Hz, 1H), 5.06 – 5.04 (m, 1H), 
4.97 – 4.94 (m, 2H), 3.61 – 3.60 (m, 1H), 3.34 – 3.33 (m, 1H), 
2.46 – 2.38 (m, 1H), 1.75 (bs, 1H); δH (100 MHz; CDCl3) 158.39 
(CH), 148.92 (CH), 139.03 (C), 137.54 (C), 136.90 (C), 134.77 
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(C), 133.83 (C), 130.75 (CH), 130.01 (CH), 127.56 (CH), 127.42 
(CH), 127.32 (CH), 129.91 (CH), 126.73 (CH), 126.70 (CH), 
122.58 (CH), 121.88 (CH), 80.92 (CH), 72.84 (CH), 72.50 (CH2), 
39.38 (CH), 34.78 (CH), 29.20 (CH2); HRMS MH
+
, C23H22NO2, 
found 344.1638, requires MH
+
 344.1651. 
(±)-{(4-Hydroxy)-8-(pyridin-3-yl)methoxy}-2,3:6,7-
dibenzobicyclo[3.3.1]nona-2,6-diene, (±)-5b. Colourless crystals 
(0.121 g, 88%) m.p. 150 – 151.5ºC decomp.; Rf (3:1 ethyl 
acetate:petroleum ether) 0.3; νmax (solution, CHCl3) 3567, 3014, 
2928, 1102, 1038 cm
-1
; δH (400 MHz; CDCl3) 8.74 (s, 1H), 8.58 
(d, J = 4.0 Hz, 1H), 7.85 (d, J = 8.0 Hz, 1H), 7.50 (d, J = 7.6 Hz, 
1H), 7.45 – 7.43 (m, 1H), 7.34 (dd, J = 4.8, 7.6 Hz, 1H), 7.28 – 
7.26 (m, 2H), 7.20 – 7.13 (m, 4H), 5.21 (d, J = 12.0 Hz, 1H), 
5.05 (d, J = 5.6 Hz, 1H), 4.90 (d, J = 4.8 Hz, 1H), 4.87 (d, J = 
12.0 Hz, 1H), 3.58 – 3.56 (m, 1H), 3.35 – 3.33 (m, 1H), 2.48 – 
2.36 (m, 2H), 1.62 (bs, 1H); δH (100 MHz; CDCl3) 149.36 (CH), 
149.25 (CH), 139.01 (C), 137.25 (C), 135.63 (CH), 134.54 (C), 
133.72 (C), 133.51 (C), 130.49 (CH), 129.99 (CH), 127.66 (CH), 
127.49 (CH), 127.31 (CH), 127.04 (CH), 126.87 (CH), 126.82 
(CH), 123.62 (CH), 80.78 (CH), 72.78 (CH), 69.24 (CH2), 39.32 
(CH), 34.91 (CH), 29.23 (CH2); HRMS MH
+
, C23H22NO2, found 
344.1633, requires MH
+
 344.1651. 
(±)-{(4-Hydroxy)-8-(pyridin-4-yl)methoxy}-2,3:6,7-
dibenzobicyclo[3.3.1]nona-2,6-diene, (±)-5c. Colourless crystals 
(0.126 g, 92%) m.p. 215-218ºC decomp.; Rf (3:1 ethyl 
acetate:petroleum ether) 0.3; νmax (solution, CHCl3) 3566, 3015, 
2928, 1605, 1101, 1036 cm
-1
; δH (400 MHz; CDCl3) 8.61 (m, 
2H), 7.53 – 7.48 (m, 2H), 7.41 (d, J = 5.2 Hz, 2H), 7.30 – 7.28 
(m, 1H), 7.22 – 7.18 (m, 3H), 7.13 – 7.09 (m, 1H), 7.05 (dd, J = 
1.2, 8.8 Hz, 1H), 5.23 (d, J = 13.6 Hz, 1H), 5.06 (d, J = 5.2 Hz, 
1H), 4.90 (d, J = 4.8 Hz, 1H), 4.87 (d, J = 13.6 Hz, 1H), 3.57 – 
3.55 (m, 1H), 3.35 – 3.34 (m, 1H), 2.49 – 2.41 (m, 2H), 1.76 (bs, 
1H); δC (100 MHz; CDCl3) 149.67 (CH), 147.59 (C), 139.05 (C), 
137.13 (C), 134.47 (C), 133.76 (C), 130.52 (CH), 130.08 (CH), 
127.67 (CH), 127.51 (CH), 127.26 (CH), 127.10 (CH), 126.87 
(CH), 126.74 (CH), 121.96 (CH), 81.17 (CH), 72.78 (CH), 69.92 
(CH2), 39.34 (CH), 34.88 (CH), 29.21 (CH2); HRMS MH
+
, 
C23H22NO2, found 344.1634, requires MH
+
 344.1651. 
4.4 General method for dialkylation.  
To a solution of the diol (±)-3 (0.100 g, 0.397 mmol) in dry 
DMSO (2.00 mL) was added the pyridylmethyl bromide HBr salt 
(0.221 g, 0.872 mmol) and the reaction mixture stirred at 0ºC 
under N2. To this mixture was added powdered KO
t
Bu (0.200 g, 
1.783 mmol) and the subsequent black reaction mixture was then 
allowed to warm to room temperature and stirred over night.  The 
reaction mixture was then poured into H2O and extracted with 
ethyl acetate (x3).  The combined organic layers were then 
washed with brine, dried (Na2SO4), filtered and the solvent 
removed in vacuo.  The crude solid was then recrystallized 
(CH2Cl2/petroleum ether) giving the following compounds; 
(±)-4,8-{(Dipyridin-2-yl)methoxy}-2,3:6,7-
dibenzobicyclo[3.3.1]nona-2,6-diene, (±)-6a. Colourless crystals 
(0.152 g, 88%) m.p. 237 – 238.5ºC; νmax (solution, CHCl3) 3014, 
2928, 2860, 1086 cm
-1
; δH (400 MHz; CDCl3) 8.59 (dd, J = 0.8, 
4.8 Hz, 4H), 7.73 (dt, J = 1.6, 7.6 Hz, 2H), 7.61 (d, J = 7.6 Hz, 
2H), 7.48 – 7.46 (m, 2H), 7.25 – 7.22 (m, 2H), 7.15 – 7.07 (m, 
6H), 5.28 (d, J = 13.2 Hz, 2H), 4.98 (d, J = 13.2 Hz, 2H), 4.96 (d, 
J = 13.6 Hz, 2H), 4.96 (d, J = 4.8 Hz, 2H), 3.63 – 3.61 (m, 2H), 
2.44 – 2.42 (m, 2H); δC (100 MHz; CDCl3) 158.61 (C), 148.98 
(CH), 136.97 (C), 136.84 (CH), 134.56 (C), 130.70 (CH), 127.00 
(CH), 126.50 (CH), 126.46 (CH), 122.51 (CH), 121.86 (CH), 
81.09 (CH), 73.37 (CH2), 34.69 (CH), 29.16 (CH2); HRMS 
MNa
+
, C29H26N2O2Na, found 457.1872, requres MNa
+
 457.1892. 
(±)-4,8-Di{(pyridin-3-yl)methoxy}-2,3:6,7-
dibenzobicyclo[3.3.1]nona-2,6-diene, (±)-6b. Colourless crystals 
(0.136 g, 79%) m.p. 203-205ºC; νmax (solution, CHCl3) 3014, 
2928, 2860, 1085 cm
-1
; δH (400 MHz; CDCl3) 8.74 (s, 2H), 8.60 
(d, J = 4.0 Hz, 2H), 7.88 (d, J = 8.0 Hz, 2H), 7.36 (dd, J = 4.8, 
7.2 Hz, 4H), 7.26 (2, 2H), 7.13 – 7.11 (m, 6H), 5.20 (d, J = 12.0 
Hz, 2H), 4.87 – 4.86 (m, 2H), 4.86 (d, J = 12.0 Hz, 2H), 3.56 – 
3.54 (m, 2H), 2.42 – 2.40 (m, 2H); δC (100 MHz; CDCl3) 148.99 
(CH), 148.85 (CH), 136.68 (C), 135.97 (CH), 135.25 (C), 133.95 
(C), 130.48 (CH), 127.21 (CH), 126.68 (CH), 126.41 (CH), 
123.79 (CH), 80.94 (CH), 69.91 (CH2), 34.83 (CH), 29.22 (CH2); 
HRMS MH
+
, C29H27N2O2, found 435.2054, requires MH
+
 
435.2073. 
(±)-4,8-Di{(pyridin-4-yl)methoxy}-2,3:6,7-
dibenzobicyclo[3.3.1]nona-2,6-diene, (±)-6c. Colourless crystals 
(0.162 g, 94%) m.p. 235 – 240ºC decomp.; νmax (solution, CHCl3) 
3014, 2928, 2860, 1085 cm
-1
; δH (400 MHz; CDCl3) 8.61 (dd, J = 
1.2, 4.4 Hz, 4H), 7.44 (d, J = 7.6 Hz, 2H), 7.40 – 7.38 (m, 4H), 
7.22 – 7.05 (m, 6H), 5.21 (d, J = 13.2 Hz, 2H), 4.89 (d, J = 4.8 
Hz, 2H), 4.86 (d, J = 13.6 Hz, 2H). 3.58 – 3.56 (m, 2H), 2.43 – 
2.41 (m, 2H); δC (100 MHz; CDCl3) 149.98 (CH), 147.34 (C), 
136.63 (C), 134.22 (C), 130.59 (CH), 127.26 (CH), 126.68 (CH), 
126.46 (CH), 121.86 (CH), 81.23 (CH), 69.77 (CH2), 34.80 (CH), 
29.16 (CH2); HRMS MH
+
, C29H27N2O2, found 435.2053, requires 
MH
+
 435.2073. 
4.5 X-ray Crystallography. 
Crystal data were collected on Bruker APEX 2 CCD 
diffractometers using narrow slice 0.3° ω-scans for (+)-
4b·CH2Cl2, (±)-4c, (±)-4d, and (±)-5c 
[12]
. Data for (±)-4c and 
(±)-5c were collected at the ALS, Station 11.3.1 using silicon 111 
monochromated X-radiation
[12]
. Data were corrected for Lp 
effects and for absorption, based on repeated and symmetry 
equivalent reflections, and solved by direct methods
[13,14]
. 
Structures were refined by full matrix least squares on F
2 [13,14]
. H 
atoms were included in a riding model. Hydrogen atom Uiso 
values were constrained to be 120% of that of the carrier atom 
except for methyl and hydroxyl-H (150%). The absolute structure 
for (+)-4b·CH2Cl2 was well determined with absolute structure 
parameter x = 0.06(7). Further details are provided in Table 1 in 
the supplementary information. CCDC 784572-784575 contain 
the supplementary crystallographic data for this paper. These data 
can be obtained free of charge from The Cambridge 
Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif
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